Description medications: Aranoza (Aranozum)
Apply with melanoma, and small cell lung cancer.
Administered intravenously at 0,55-0,8 g / m 2 (glucose solution) for three consecutive days every 4 weeks.
Possible side effects: nausea, vomiting, leukopenia, thrombocytopenia.
Product: dried powder for injection solutions in vials of 0.5 g
Storage: List A.